Literature DB >> 33457135

The Association Between Hypertension and Cognitive Impairment, and the Role of Antihypertensive Medications: A Literature Review.

Nupur Mishra1, Devyani Mohan2, Sehrish Fuad1, Deepak M Basavanagowda3, Zaid A Alrashid4, Arveen Kaur3, Bindu Rathod3, Sadia Nosher5, Stacey E Heindl1,6.   

Abstract

Vascular dementia (VD) is one of the leading causes of dementia, and hypertension is a known risk factor for VD. Hypertension treatment guidelines have previously discussed an optimal blood pressure goal to prevent further cardiovascular complications with long-term management. The treatment of hypertension can prevent stroke, kidney failure, and perhaps prevent cognitive decline as well. We reviewed studies that demonstrated an association between hypertension and cognitive impairment (CI). The role of antihypertensive medications (AHM) in preventing CI was also investigated. This topic is worth exploring as dementia has high healthcare costs and will become prominent as the population in the United States ages. We used the medical subject heading (MeSH) search strategy on Pubmed and reviewed 22 articles. The studies showed that there might be a link between hypertension, AHM, and CI. The studies did not suggest a superiority of any specific AHM class to prevent CI. Further research on optimal hypertension treatment goals to prevent cognitive impairment and dementia is recommended.
Copyright © 2020, Mishra et al.

Entities:  

Keywords:  ace inhibitors; angiotensin receptor blockers; antihypertensive medications; blood pressure; calcium channel blockers; cognition; cognitive impairment; dementia; hypertension; thiazide diuretics

Year:  2020        PMID: 33457135      PMCID: PMC7797448          DOI: 10.7759/cureus.12035

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  50 in total

Review 1.  Factors for predicting reversion from mild cognitive impairment to normal cognition: A meta-analysis.

Authors:  HuiPing Xue; Ping Hou; YongNan Li; Xin'e Mao; LinFeng Wu; YongBing Liu
Journal:  Int J Geriatr Psychiatry       Date:  2019-07-04       Impact factor: 3.485

2.  Age-Related Effect of Antihypertensive Treatment on Cognitive Performance: Is it Better Preventing Dementia in Older Age?

Authors:  Reza Vazirinejad; Maryam Mirmotalebi; Monireh Bageri; Nicholas G Kounis; Ioanna Koniari; Jeanette M Lilley; Nasser Gommnami
Journal:  Am J Alzheimers Dis Other Demen       Date:  2019-07-17       Impact factor: 2.035

Review 3.  Left ventricular hypertrophy in association with cognitive impairment: a systematic review and meta-analysis.

Authors:  Marios K Georgakis; Andreas Synetos; Constantinos Mihas; Maria A Karalexi; Dimitrios Tousoulis; Sudha Seshadri; Eleni Th Petridou
Journal:  Hypertens Res       Date:  2017-02-16       Impact factor: 3.872

4.  Hypertension guideline update: A new guideline for a new era.

Authors:  Sondra M DePalma; Cheryl Dennison Himmelfarb; Eric J MacLaughlin; Sandra J Taler
Journal:  JAAPA       Date:  2018-06

5.  Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the systolic hypertension in the elderly program.

Authors:  W B Applegate; S Pressel; J Wittes; J Luhr; R B Shekelle; G H Camel; M R Greenlick; E Hadley; L Moye; H M Perry
Journal:  Arch Intern Med       Date:  1994-10-10

6.  Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial.

Authors:  Ruth Peters; Nigel Beckett; Francoise Forette; Jaakko Tuomilehto; Robert Clarke; Craig Ritchie; Adam Waldman; Ivan Walton; Ruth Poulter; Shuping Ma; Marius Comsa; Lisa Burch; Astrid Fletcher; Christopher Bulpitt
Journal:  Lancet Neurol       Date:  2008-07-07       Impact factor: 44.182

7.  Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial.

Authors:  Jeff D Williamson; Nicholas M Pajewski; Alexander P Auchus; R Nick Bryan; Gordon Chelune; Alfred K Cheung; Maryjo L Cleveland; Laura H Coker; Michael G Crowe; William C Cushman; Jeffrey A Cutler; Christos Davatzikos; Lisa Desiderio; Guray Erus; Larry J Fine; Sarah A Gaussoin; Darrin Harris; Meng-Kang Hsieh; Karen C Johnson; Paul L Kimmel; Manjula Kurella Tamura; Lenore J Launer; Alan J Lerner; Cora E Lewis; Jennifer Martindale-Adams; Claudia S Moy; Ilya M Nasrallah; Linda O Nichols; Suzanne Oparil; Paula K Ogrocki; Mahboob Rahman; Stephen R Rapp; David M Reboussin; Michael V Rocco; Bonnie C Sachs; Kaycee M Sink; Carolyn H Still; Mark A Supiano; Joni K Snyder; Virginia G Wadley; Jennifer Walker; Daniel E Weiner; Paul K Whelton; Valerie M Wilson; Nancy Woolard; Jackson T Wright; Clinton B Wright
Journal:  JAMA       Date:  2019-02-12       Impact factor: 56.272

Review 8.  Blood pressure and the risk for dementia: a double edged sword.

Authors:  Sean P Kennelly; B A Lawlor; R A Kenny
Journal:  Ageing Res Rev       Date:  2008-11-21       Impact factor: 10.895

9.  Blood pressure variability: clinical relevance and application.

Authors:  Gianfranco Parati; George S Stergiou; Eamon Dolan; Grzegorz Bilo
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-07       Impact factor: 3.738

10.  A randomised controlled trial of calcium channel blockade (CCB) with Amlodipine For the treatment oF subcortical ischaEmic vasCular demenTia (AFFECT): study protocol.

Authors:  Caroline Greenan; Lynn Murphy; Ly-Mee Yu; Patrick G Kehoe; Elizabeth Coulthard; Philip Bath; Robert Stewart; Rob Jones; Anne Corbett; Alan Thomas; Peter Connelly; Frank Arrojo; Rachel Canning; Sylvia Wallach; Catherine Henderson; Bernadette McGuinness; Mike O'Sullivan; Clive Holmes; Martin Knapp; Clive Ballard; Peter Passmore
Journal:  Trials       Date:  2016-07-18       Impact factor: 2.279

View more
  1 in total

Review 1.  AT1 Receptors: Their Actions from Hypertension to Cognitive Impairment.

Authors:  Hanxue Wu; Qi Sun; Shenglan Yuan; Jiawei Wang; Fanni Li; Hongli Gao; Xingjuan Chen; Rui Yang; Jiaxi Xu
Journal:  Cardiovasc Toxicol       Date:  2022-02-24       Impact factor: 2.755

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.